Advertisement

Amino Acids

, Volume 38, Issue 1, pp 223–228 | Cite as

mTOR phosphorylated at S2448 binds to raptor and rictor

  • M. Rosner
  • N. Siegel
  • A. Valli
  • C. Fuchs
  • M. HengstschlägerEmail author
Original Article

Abstract

In mammalian cells, the mammalian target of rapamycin (mTOR) forms an enzyme complex with raptor (together with other proteins) named mTOR complex 1 (mTORC1), of which a major target is the p70 ribosomal protein S6 kinase (p70S6K). A second enzyme complex, mTOR complex 2 (mTORC2), contains mTOR and rictor and regulates the Akt kinase. Both mTORC1 and mTORC2 are regulated by phosphorylation, complex formation and localization. So far, the role of p70S6K-mediated mTOR S2448 phosphorylation has not been investigated in detail. Here, we report that endogenous mTOR phosphorylated at S2448 binds to both, raptor and rictor. Experiments with chemical inhibitors of the mTOR kinase and of the phosphatidylinositol-3-kinase revealed that downregulation of mTOR S2448 phosphorylation correlates with decreased mTORC1 activity but can occur decoupled of effects on mTORC2 activity. In addition, we found that the correlation of the mTOR S2448 phosphorylation status with mTORC1 activity is not a consequence of effects on the assembly of mTOR protein and raptor. Our data allow new insights into the role of mTOR phosphorylation for the regulation of its kinase activity.

Keywords

mTOR Phosphorylation Raptor Rictor 

Notes

Acknowledgments

Research in our laboratory is supported by the FWF Austrian Science Fund (P18894-B12), by the Marie Curie Research Network of the European Community (FP6 036097-2) and by the Herzfelder′sche Familienstiftung.

References

  1. Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12:487–502. doi: 10.1016/j.devcel.2007.03.020 CrossRefPubMedGoogle Scholar
  2. Burgstaller S, Rosner M, Lindengrün C, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M (2008) Tuberin, p27 and mTOR in different cells. Amino Acids. doi: 10.10007/100726-008-0066-1
  3. Chiang GG, Abraham RT (2005) Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem 280:25485–25490. doi: 10.1074/jbc.M501707200 CrossRefPubMedGoogle Scholar
  4. Chiang GG, Abraham RT (2007) Targeting the mTOR signaling network in cancer. Trends Mol Med 13:433–442. doi: 10.1016/j.molmed.2007.08.001 CrossRefPubMedGoogle Scholar
  5. Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13:252–259. doi: 10.1016/j.molmed.2007.04.002 CrossRefPubMedGoogle Scholar
  6. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9–22. doi: 10.1016/j.ccr.2007.05.008 CrossRefPubMedGoogle Scholar
  7. Holz MK, Blenis J (2005) Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem 280:26089–26093. doi: 10.1074/jbc.M504045200 CrossRefPubMedGoogle Scholar
  8. Rosner M, Hengstschläger M (2007) Cytoplasmic/nuclear localization of tuberin in different cell lines. Amino Acids 33:575–579. doi: 10.1007/s00726-007-0541-0 CrossRefPubMedGoogle Scholar
  9. Rosner M, Hengstschläger M (2008) Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet 17:2934–2948. doi: 10.1093/hmg/ddn192 CrossRefPubMedGoogle Scholar
  10. Rosner M, Freilinger A, Hengstschläger M (2004) Proteins interacting with the tuberous sclerosis gene products. Amino Acids 27:119–128. doi: 10.1007/s00726-004-0119-z CrossRefPubMedGoogle Scholar
  11. Rosner M, Freilinger A, Hanneder M, Fujita N, Lubec G, Tsuruo T, Hengstschläger M (2007) p27Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet 16:1541–1556. doi: 10.1093/hmg/ddm103 CrossRefPubMedGoogle Scholar
  12. Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M (2008) The mTOR pathway and its role in human genetic diseases. Mutat Res 659:284–292. doi: 10.1016/j.mrrev.2008.06.001 CrossRefPubMedGoogle Scholar
  13. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101. doi: 10.1126/science.1106148 CrossRefPubMedGoogle Scholar
  14. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22:159–168. doi: 10.1016/j.molcel.2006.03.029 CrossRefPubMedGoogle Scholar
  15. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124:471–484. doi: 10.1016/j.cell.2006.01.016 CrossRefPubMedGoogle Scholar
  16. Yang Q, Guan K-L (2007) Expanding mTOR signaling. Cell Res 17:666–681. doi: 10.1038/cr.2007.64 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • M. Rosner
    • 1
  • N. Siegel
    • 1
  • A. Valli
    • 1
  • C. Fuchs
    • 1
  • M. Hengstschläger
    • 1
    Email author
  1. 1.Medical GeneticsMedical University of ViennaViennaAustria

Personalised recommendations